Henry Schein (HSIC) Reports In-Line Q3 EPS; Offers FY22 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
Henry Schein Reports Record Non-GAAP Third-Quarter 2022 Diluted EPS Financial Results
November 1, 2022 6:30 AM EDTNet sales of $3.1 billion decreased 3.5% compared with the third-quarter 2021; internal sales increased 6.8% in local currencies when excluding sales of PPE and COVID-19 test kits GAAP diluted EPS of $1.09 compared with third-quarter 2021 GAAP diluted EPS of $1.15 Non-GAAP diluted EPS of $1.15 compared with third-quarter 2021 non-GAAP diluted EPS of $1.10 Full-year 2022 non-GAAP diluted EPS guidance of $4.79 to $4.87
MELVILLE, N.Y.--(BUSINESS WIRE)-- Henry Schein, Inc. (Nasdaq: HSIC), the worlds largest provider of health care solutions to office-based dental and medical practitioners, today reported record... More
